Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health
Five things we've learned about the BA.4 and BA.5 Omicron variants | Gavi, the Vaccine Alliance
FDA recommends including omicron subvariants BA.4 and BA.5 in fall Covid boosters
Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study | The BMJ
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection | Nature
Bivalent COVID Shots May Hold Up Better Against Severe Omicron | MedPage Today
Pfizer and BioNTech seek emergency use authorization for Omicron BA.4/5-adapted booster vaccine
Moderna su LinkedIn: Moderna's Omicron-Containing Bivalent Booster Candidate, mRNA-1273.214… | 13 commenti
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine | Australian Government Department of Health and Aged Care
News - CHMP Recommends Authorisation of Comirnaty Variant (BioNTech/Pfizer) Adapted to Omicron BA.4/BA.5 As Booster Vaccination for Children Aged 5 to 11 Years - Paul-Ehrlich-Institut
First data on Pfizer-BioNTech's Omicron BA.4/5 combination vaccine
Updated Covid-19 boosters offer protection, but new studies suggest they don't offer an edge against Omicron | CNN
AIFA autorizza il vaccino bivalente Comirnaty Original per le varianti Omicron BA.4-5
Omicron boosters: Do I need another COVID-19 shot, and when? | COVID | Prevention | UT Southwestern Medical Center
News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut
Health Canada approves Moderna's COVID-19 vaccine for Omicron BA.4/BA.5 variants | CBC News
Moderna seeks FDA nod for booster shot aimed at Omicron BA.4, BA.5 | Reuters
Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice | Science Immunology
What's the risk if I wait for an updated bivalent COVID booster?
Moderna on X: "ANNOUNCEMENT 📢: The first participant has been dosed in a Phase 2/3 trial of mRNA-1273.222, a bivalent #COVID19 #booster vaccine candidate targeting the original and #Omicron BA.4/5 strains of